Your shopping cart is currently empty

RO5234444 is an orally active CCR2 antagonist, exhibiting an IC50 of 22 nM for human CCR2 and 161 nM for mouse CCR2. It mitigates glomerulosclerosis in a unilateral nephrectomy type 2 diabetes db/db mouse model, reduces proteinuria, and significantly improves glomerular filtration rate. RO5234444 is applicable for research in type 2 diabetic nephropathy.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | RO5234444 is an orally active CCR2 antagonist, exhibiting an IC50 of 22 nM for human CCR2 and 161 nM for mouse CCR2. It mitigates glomerulosclerosis in a unilateral nephrectomy type 2 diabetes db/db mouse model, reduces proteinuria, and significantly improves glomerular filtration rate. RO5234444 is applicable for research in type 2 diabetic nephropathy. |
| Targets&IC50 | CCR2 (human):22 nM |
| Molecular Weight | 463.98 |
| Formula | C24H31ClFN3O3 |
| Cas No. | 1365266-79-0 |
| Smiles | O[C@H]1C2(CC2)CCN(CCCN3C(=O)[C@H](C)N(C(C=CC4=CC(Cl)=C(F)C=C4)=O)CC3)C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.